Skip to Content
Merck

Meningeal fibrosarcoma: a case report and review of the literature.

Acta neurologica Belgica (1992-01-01)
A Rovirosa, P Vicente, J Bellmut, S Morales, J M Del Campo, R Bodi, A Ortega
ABSTRACT

Meningeal Fibrosarcoma (MF) accounts only for 0.5% of the brain tumors. Since the clinical manifestations and radiologic findings are non-specific, the diagnosis can only be achieved by pathological examination of surgically removed specimens. MF are tumors that behave locally very aggressively and respond poorly to treatment, with reported median survivals ranging from 6 to 15 months. We report a new case of MF describing the peculiar onset as a slow growing mass in scalp with bone destruction and without neurological clinical findings.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Orientin, ≥97% (HPLC)